Hepatitis B, hepatitis C and human immunodeficiency virus seropositivity among children in Kabul, Afghanistan: A cross-sectional study

Hepatitis Monthly

Volumn 14, Issue 3, 2013, Pages

  Tanju, Ilhan Asya ^a   Levent, Fatma ^b   Sezer, Rabia Gonul ^c   Cekmez, Ferhat ^d  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^c Zeynep Kamil Maternity and Childrens Diseases Training and Research Hospital   (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Hepatitis B virus; Hepatovirus; HIV; Pediatrics

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADOLESCENT; AFGHANISTAN; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; VACCINATION;

EID: 84897911031     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.16154     Document Type: Article

References (15)

1. World Health Organization. Global distribution of hepatitis A, B and C. Weekly Epidemiological Record.: WHO; 2002. Available from: http://www.who.int/docstore/wer/pdf/2002/wer7706.pdf.
2. Krasteva A, Panov VE. Hepatitis B and C in Dentistry. J IMAB. 2008;14(2):38-40.
3. Afghanistan National Strategic Framework for HIV/AIDS. National HIV/AIDS and STI Control Programme. Islamic Republic of Afghanistan: Ministry of Public Health; 2006-2010. Available from: http://www.hsph.harvard.edu/population/aids/afghanistan.aids.06.pdf.
4. Macmillan P. Human Development Report 2009.New York, USA: Human mobility and development United Nations Development Programm (UNDP 2009); 2009.
5. Khan NU, Siddique L, Ali I, Iqbal A, Munir I, Rashid F, et al. Prevalence of hepatitis B in the blood donors of NW. FP and FATA regions and the current scenario of HBV infection in Pakistan. African J Biotech. 2013;9(37):6162-6.
6. Central Blood Bank. Report of Testing of Blood Donors from MarchDecember, 2006.Kabul, Afghanistan: Ministry of Public Health; 2006.
7. Todd CS, Abed AM, Strathdee SA, Scott PT, Botros BA, Safi N, et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis. 2007;13(9):1327-31.
8. Todd CS, Ahmadzai M, Atiqzai F, Miller S, Smith JM, Ghazanfar SA, et al. Seroprevalence and correlates of HIV, syphilis, and hepatitis B and C virus among intrapartum patients in Kabul, Afghanistan. BMC Infect Dis. 2008;8:119.
9. Nasir A, Todd CS, Stanekzai MR, editors. Prevalence of HIV, viral hepatitis, syphilis and risk behaviors among injection drug users in Herat, Afghanistan.; International AIDS Conference.2008; Mexico.
10. Quddus A, Luby SP, Jamal Z, Jafar T. Prevalence of hepatitis B among Afghan refugees living in Balochistan, Pakistan. Int J Infect Dis. 2006;10(3):242-7.
11. Pourkarim MR, Zandi K, Davani NA, Pourkarim HR, Amini-Bavil-Olyaee S. An aberrant high prevalence of hepatitis B infection among Afghans residing in one of the Bushehr refugee camps (Dalaki camp) in the southwest of Iran. Int J Infect Dis. 2008;12(1):101-2.
12. Mapping and Situation Assessment of Key Populations at High Risk of HIV in Three Cities of Afghanistan. South Asia Region: Human Development Sector; 2008. Available from: http://www.hivpolicy.org/Library/HPP001838.pdf.
13. Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis. 2009;13(1):9-19.
14. Todd CS, Nasir A, Stanekzai MR, Bautista CT, Botros BA, Scott PT, et al. HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities. AIDS. 2010;24 Suppl 2:S69-75.
15. Khan S, Attaullah S. Share of Afghanistan populace in hepatitis B and hepatitis C infection's pool: is it worthwhile? Virol J. 2011;8:216.